Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amoliv
- Development stage
- Unknown
- Lead developer
- Amogh Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Amoliv is an Ayurvedic herbal formulation developed and manufactured by Amogh Pharmaceuticals. It is primarily used as a hepatoprotective and hepatocorrective tonic to detoxify and normalize liver functions, improve metabolism, and stimulate appetite. The formulation is composed of various traditional Indian medicinal herbs, including Giloy (*Tinospora cordifolia*), Punarnava (*Boerhavia diffusa*), Kalmegh (*Andrographis paniculata*), Bhui amla (*Phyllanthus niruri*), Triphala, Tulsi (*Ocimum sanctum*), and Kutki (*Picrorhiza kurroa*). Amoliv is indicated for conditions such as loss of appetite (anorexia), acute and chronic viral hepatitis, fatty liver infiltration, jaundice (hyperbilirubinemia), and hepatotoxicity induced by alcohol, chemotherapy, or anti-tubercular drugs (ATD). It is available in multiple dosage forms, including drops, capsules, and syrups (including sugar-free variants).
- Brand names
- Amogh Amoliv DS CapsulesAmogh Amoliv DS SF SyrupAmogh Amoliv DropsAmogh Amoliv SF SyrupAmoliv DS Syrup
- Other names
- Amoliv D.S. SF SyrupAmoliv D.S. SyrupAmoliv DS CapsulesAmoliv DropsAmoliv SF Syrup
Beyond the preview
Go deeper on Amoliv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amoliv.